Date and time: Tuesday November 3, 2020, 14:00 – 17:00 (Central European Time, CET)

Organization: Clinical lipidomics interest group in International Lipidomics Society, free to everyone, online using Zoom

Please note that the meeting has a new link below which requires registration via Zoom!


14:00 – 14:10Michal Holčapek (University of Pardubice, Czech Republic) – Welcome and opening
14:10 – 14:40Timothy J. Garrett (University of Florida, Gainesville, FL, USA) – Lost in translation, a research mass spectrometrist in clinical pathology
14:40 – 15:10Michael Vogeser (University of Munich (LMU), Germany) – Lipidomics-based in-vitro diagnostics – a clinical pathologist‘s perspective
15:10 – 15:25Günter Fauler (Medical University of Graz, Austria) – Routine analysis of lipids, a lot of challenges in a clinical laboratory
15:25 – 15:40Hans-F. Schött (SLING – Singapore Lipidomics Incubator, Singapore) – Steroids as diagnostic markers for inherited lipid metabolic disorders
15:40 – 15:55Uliana Danilenko (Centers for Disease Control and Prevention, Atlanta, GA, USA) – CDC Clinical Standardization Programs to improve accuracy and reliability of biomarker measurements in patient care and research
15:55 – 16:10Russell P. Grant (LabCorp, Burlington, NC, USA) – Analysis of Lipophilic Vitamins and The Slippery Slope of Perfection
16:10 – 16:40Elisabeth Erhardtsen (Nordic Bioscience, Denmark) – Regulatory pathways for approval of biomarkers
16:40 – 17:00Discussion
Topics: regulatory requirements to achieve approval to market for new biomarker(s), clinical validation, single biomarker vs. analyte panel (large or small) and how to quantitate according to regulatory requirements, certified reference materials, calibrators, lipid class or lipid species internal standards.

Michal Holčapek, Anne K. Bendt, Michael Vogeser, and Peter Meikle

Steering committee of Clinical lipidomics IG